Vestibulocerebellar function in channelopathy mutants

通道病突变体的前庭小脑功能

基本信息

  • 批准号:
    6622048
  • 负责人:
  • 金额:
    $ 26.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-02-05 至 2005-01-31
  • 项目状态:
    已结题

项目摘要

The cerebellum is a critical component of the neural circuitry that stabilizes the eyes during head movements, and disorders of the cerebellum uniformly degrade vision. Its exact computational role remains controversial, but a key to its function may lie in the high degree to which the unique architecture and conductances of its neurons have been conserved though evolution. Studying the effects of altering this conserved features would give insight into the computational processes they support. This approach is now feasible, as research in genetics and molecular biology has identified mouse strains harboring mutations in the P-type calcium channel, which is concentrated in the cerebellum and plays a key role in defining the electrophysiological characteristics of the Purkinje cell. This project will characterize the ocular motor abnormalities of mice with P-channel mutations, and use neuronal recordings to prove that these abnormalities are referable to disordered cerebellar signal processing. Specific Aim 1 and 2 will test the hypothesis that the dynamic and spatial characteristics of compensatory eye movements (such as vestibulo-ocular reflex, VOR), are disordered in the mutant strains. Specific aim 3 will test the hypothesis that mutants have specific deficits in the ability to alter the gain or direction of the VOR. Together, specific aims 1-3 will identify a set of abnormalities suitable for subsequent investigation with electrophysiological techniques. Specific aim 4 will initiate the electrophysiological investigation by testing the hypothesis that dysfunction in the inferior olive (which also expressed the P-channel) can be eliminated as a source of the mutants' ocular abnormalities. Calcium channel mutations have been implicated in human diseases such as familial migraine and episodic ataxia. Thus, the insights into normal cerebellar function generated by this study should also advance our understanding of mechanisms of heritable neurological disease.
小脑是在头部运动时稳定眼睛的神经回路的关键组成部分,小脑的紊乱会一致地降低视力。它的确切计算作用仍然存在争议,但其功能的关键可能在于其神经元的独特结构和电导在进化过程中得到高度保守。研究改变这一保守特征的效果将使我们深入了解它们所支持的计算过程。这种方法现在是可行的,因为遗传学和分子生物学的研究已经确定了P型钙通道存在突变的小鼠品系,P型钙通道集中在小脑,在确定浦肯野细胞的电生理特征方面发挥着关键作用。该项目将表征P通道突变小鼠的眼运动异常,并使用神经元记录来证明这些异常与小脑信号处理障碍有关。具体目标1和2将检验这样的假设,即在突变菌株中,代偿性眼球运动(如前庭眼球反射,VOR)的动态和空间特征是紊乱的。具体目标3将检验这样一种假设,即突变体在改变VOR的增益或方向的能力方面存在特定缺陷。总之,特定的AIMS 1-3将识别一组适合于随后使用电生理技术进行研究的异常。具体目标4将通过测试下橄榄(也表达P通道)的功能障碍可以作为突变体眼睛异常的来源而被消除的假设来启动电生理学研究。钙通道突变与家族性偏头痛和发作性共济失调等人类疾病有关。因此,这项研究对正常小脑功能的洞察也应该促进我们对遗传性神经疾病机制的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN SAMUEL STAHL其他文献

JOHN SAMUEL STAHL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN SAMUEL STAHL', 18)}}的其他基金

Purkinje Cell Rhythmicity, Synchrony, and Enhancing Function in Cerebellar Disorders
小脑疾病中浦肯野细胞的节律性、同步性和增强功能
  • 批准号:
    10337182
  • 财政年份:
    2017
  • 资助金额:
    $ 26.78万
  • 项目类别:
Purkinje Cell Rhythmicity, Synchrony, and Enhancing Function in Cerebellar Disorders
小脑疾病中浦肯野细胞的节律性、同步性和增强功能
  • 批准号:
    9490189
  • 财政年份:
    2017
  • 资助金额:
    $ 26.78万
  • 项目类别:
Purkinje Cell Rhythmicity, Synchrony, and Enhancing Function in Cerebellar Disorders
小脑疾病中浦肯野细胞的节律性、同步性和增强功能
  • 批准号:
    9346859
  • 财政年份:
    2017
  • 资助金额:
    $ 26.78万
  • 项目类别:
Principles of Therapy in Cerebellar Disease: Explorations in Ion Channel Mutants
小脑疾病的治疗原则:离子通道突变体的探索
  • 批准号:
    8391125
  • 财政年份:
    2009
  • 资助金额:
    $ 26.78万
  • 项目类别:
Principles of Therapy in Cerebellar Disease: Explorations in Ion Channel Mutants
小脑疾病的治疗原则:离子通道突变体的探索
  • 批准号:
    8195580
  • 财政年份:
    2009
  • 资助金额:
    $ 26.78万
  • 项目类别:
Principles of Therapy in Cerebellar Disease: Explorations in Ion Channel Mutants
小脑疾病的治疗原则:离子通道突变体的探索
  • 批准号:
    7786277
  • 财政年份:
    2009
  • 资助金额:
    $ 26.78万
  • 项目类别:
Principles of Therapy in Cerebellar Disease: Explorations in Ion Channel Mutants
小脑疾病的治疗原则:离子通道突变体的探索
  • 批准号:
    7687751
  • 财政年份:
    2009
  • 资助金额:
    $ 26.78万
  • 项目类别:
Vestibulocerebellar function in channelopathy mutants
通道病突变体的前庭小脑功能
  • 批准号:
    6708038
  • 财政年份:
    2002
  • 资助金额:
    $ 26.78万
  • 项目类别:
Vestibulocerebellar function in channelopathy mutants
通道病突变体的前庭小脑功能
  • 批准号:
    6438428
  • 财政年份:
    2002
  • 资助金额:
    $ 26.78万
  • 项目类别:
OCULOMOTOR RANGE IN HEALTH AND DISEASE
健康和疾病中的动眼范围
  • 批准号:
    5200052
  • 财政年份:
    1996
  • 资助金额:
    $ 26.78万
  • 项目类别:

相似海外基金

L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
  • 批准号:
    10668210
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
  • 批准号:
    10603554
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
  • 批准号:
    10684558
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
  • 批准号:
    10815882
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
  • 批准号:
    10628914
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
  • 批准号:
    10734121
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
  • 批准号:
    10628911
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
  • 批准号:
    2200474
  • 财政年份:
    2022
  • 资助金额:
    $ 26.78万
  • 项目类别:
    Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
  • 批准号:
    452107
  • 财政年份:
    2021
  • 资助金额:
    $ 26.78万
  • 项目类别:
    Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
  • 批准号:
    10399417
  • 财政年份:
    2021
  • 资助金额:
    $ 26.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了